研究成果    
学术动态
2018-08-13
为了更好地落实“共商、共建、共享、共赢”的大会宗旨,探索1型糖尿病的分级诊疗模...
最新公告
2023-09-09
9月7-9日,国家代谢性疾病临床医学研究中心十周年代谢内分泌疾病学术会议在湖南长...
英文论文

1. David Kreutter, Toshio Matsumoto, Roger Peckham, Kathleen Zawalich, Wu Hanwen, David T, Zolceks and Howard Rasmussen. Lack of essential fatty acids to 1, 25 (OH) 2 D, stimulating bowel to on the absorption of calcium必需脂肪酸缺乏对于1,25(OH)2D,刺激肠对钙吸收的影响. J Biol Chem, 1983, 258: 4977~4981.

2. Huiping Song, Xiuyun Han, Yuan He, Tiebang Kang, Hanwen Wu. Activities of aldose reductase, ATPases, and nuclotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. Chinese Medical Journal, 1991, 104(10): 818~824.

3. Xiangbing Wang, Hanwen Wu, and Chusheng Chao. Effect of Propranolol on Calcium, Phosphorus, and Magnesium Metabolic Disorders in Graves’ Disease. Metabolism, 1992, 41: 552~555.

4. Hanwen Wu, et al. Clinical Analysis of 35 Families with Fragile X Syndrome. First China-Japan Human Genetics Symposium, Beijing, October 1992, 8~10, 11.

5. Zhou Zhi-guang, Liao Er-yuan, Wu Han-wen,Chao Chu-sheng,MoZhao-hui. Comparison of the effects of anisodamine and captopril on renal function in patients with diabetic nephropathy. China-Japan Medical Conference, 1992, 1: 159.

6. Wu Han-wen. The occurrence and treatment of primary and secondary osteoporosis. China-Japan Medical Conerence, 1992, 1: 186.

7. Longbin Liu, Xiangbin Wang, Zhusan Lin, and Hanwen Wu. Elevated Plasma Levels of VMF: Ag in Hyperthyroidism Are Mediated Through Beta-Adrenergic Receptors. Endocrine Research, 1993, 19(2&3), 123~133.

8. Wang Y.L., Wu H.W., Zhon J.K., Peng A.X. Change of BMC and Related Endocrine Tests in Patients with Throid Cancer in Thyroidectomy. The 10th Asia-Oceania Congress of Endocrinology, Astracts,Beijing,China, 1994, 201.

9. Deng X.G., Wu H.W., Chao C.S., Zhou Z.G., Liao E.Y. The Primary Observation of the Differences in Phosphatase and Bone Formation of the Bone Surface cells From New-Born Rat’s Calvaria in Vitro. The 10th Asia-Oceania Congress of Endocrinology. Astracts. Beijing,China, 1994, 213.

10. Zhong X.H., Chao C.S., Liao E.Y., Wu H.W. The Clinical Significance of Circadian Rhythm of Thyrotropin as a Parameter of Therapeutic Evaluatic in Hyperthyroidism. The 10th Asia-Oceania Congress of Endocrinology. Astracts. Beijing,China, 1994, 392.

11. Zaijin Jian, Zhuohui Han, Hanwen Wu, Jingchao Xie, Zhengsheng Mo, Fuqing He, Dengke Wang, Chen Gangren. A Study on Oliguric Standard in the Elderly. Chinese Medical Journal, 1995, 108(11): 825~828.

12. Min Hu, Yangsong Wu, Hanwen Wu. Effects of lithium deficiency in some insulin-sensitive tissues of diabetes Chinese hamsters. Biol Tr E1 Res (U.S.A.), 1997, 58: 91~102.

13. Min Hu, Hanwen Wu, Chusheng Chao. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes. Biol Tr E1 Res (U.S.A.), 1997, 60: 131~137.

14. Min Hu, Yangong Wu, Hanwen Wu. Preliminary observation on the metabolism in spontaneous hereditary diabetic Chinese hamster (shanyi colony). Chinese Medical Yournal, 1997, 110(9): 711~714.

15. J.Wang, Z.Zhou, J.Wen, H.Wu and T.Dyrberg. Glutamic acid decarboxylase a autoantibody assay in Chinese IDDM patients. 23rdInternational Congress of Internal Medicine. 441~445.

16. Yanlin Wang, Hanwen Wu. Newborn bone mineral density and Health care during pregnancy. J Bone and Mineral Metabolism, 1998, 16: 190~192.

17. Min Hu, Yangsong Wu, Hanwen Wu. Influence of streptozotocin-Induced Diabetes in Rats on the Lithium Content of Tissue and the Effect of Dietary Lithium Supplements on This Diabetic Condition. Metabolism, 1999, 48(5): 558~563.

18. Shaobin Duan, Hanwen Wu, JiAn Luo, Fuyou Liu. Assessment of Renal Function in the Early Stages of Nephrotoxicity Induced by Iodinated Contrast Media. Nephron, 1999, 83: 122~125.

19. Hanwen Wu, Zhiguang Zhou, Wen Yang, Zhulin Yang, OuYang Lingli, Zhu Lin, Wang Jianmin, Peng Jian, Zhu Xuping, Wen Jianxin, Zhou Houde, Zhao Wenwei, Thomas Dyrberg. Special lecture I. The Current Research Status of LADA inChina. The 6th Japan-China Friendship Symposium on Diabetes Mellitus. Nov. 18~21, 1999,Matsuyama,Japan. p14.

20. Zhou Z, Ouyang L, Peng J, Yang W, Wang JM, Zhu XP, Wu HW, Thomas Dyrberg. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults. Chinese Medical Journal, 1999, 112(6): 554~557.

21. Wu Hanwen and Zhou Zhiguang. Abnormal Oxygen Transportation is the Key Link of Formation of Diabetic Nephropathy (DN). An International Conference on Life Science and Cinical Medicine 2000, Proceedings and Abstracts, 2000, April 19~21,Beijing,China, p324.

22. Deng XG, Liao EY, Wu XP, Zhou Z, Huang G, Jian ZJ, Peng XL, Wu HW. Bone mineral density differences at the femoral neck and Ward’s triangle: a comparison study on the reference data between Chinese and Caucasian women. Calcif Tissue Int, 2000, 67: 195~198.

23. Deng XG, Wang WB, Wu XP, Huang G, Peng J, Liao EY, Wu HW. Correlation Between Bone Mineral Density and Sexual Hormones in Healthy Chinese Women. Journal of Environmental Pathology, Toxicology and Oncology, 2000, 19(1): 167~169.

24. S.-B. Duan, F.-Y, Liu, J.-A. Luo, H,-W. Wu, R.-H. Liu, Y.-M. Peng and X.-L. Yang. Nephrotoxicity of high-and low-osmolar contrast media: The protective role of amlodipine in a rat model. Acta Radiologica, 2000, 41: 503~507.

25. Er-yuan Liao, Xiang-hang Luo. Effects of 17β-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 inhuman osteoblast-like cells cultures. Endocrine, 2001, 15(3): 1~5.

26. Liao Eryuan, Luo Xianghang. Effects of 17b-estradiol on the expression of nembrane-type matrix metalloproteinase-1(MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human osteoblastic MG-63 cell cultures. J Endocrinol Invest, 2001, 24: 876~881. (IF=1.347)

27. Luo Xianghang, Liao Eryuan. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1-MMP) compartment of pro MMP-2 activation in MG-63 cells. Horm Metab Res, 2001, 33: 383~388.

28. Liao EY, Luo XH, Su X. Comparison of the effects of 17β-E2 and progesterone on the expression on osteoprotegerin in hormal human osetoblast-like cells. J Endocrinol Invest, 2002, 25(9): 785~790. (IF=1.347)

29. Liao EY, Wu XP, Deng XG, Huang G, Zhu XP, Long ZF, Wang WB, Tang WL, Zhang H. Age-related hone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in Chinese women. Osteoporos International, 2002, 13(8): 669~676.

30. Luo XH, Liao EY, Su X. Progesterone upregulates TGF-6 isoforms (b1, b2and B3) expression in normal human osteoblast-line cells. Calcif Tissue, International, 2002, 71(4): 329~334.

31. Liao EY, Liao HJ, Luo XH, Dai RC, Zhou HD. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo. J Endocrinol Invest, 2003, 26: 710~716. (IF=1.347)

32. Liao EY, Luo XH, Deng XG, Wu XP, Liao HJ, Wang PF, Mao JP, Zhu XP, Huang G, Wei QY. The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis. Endocr Res, 2003 May, 29(2): 217~226.

33. Liao EY, Luo XH, Wang WB, Wu XP, Zhou HD, Dai RC, Liao HJ, Yang C. Effects of different nylestriol/levonorgestrel dosages on bone metabolism in female Sprague-Dawley rats with retinoic acid-induced osteoporosis. Endocr Res, 2003 Feb, 29(1): 23~42.

34. Liao EY, Wu XP, Luo XH, Zhang H, Dai RC, Huang G, Wang WB. Establishment and evaluation of bone mineral density reference databases appropriate for diagnosis and evaluation of osteoporosis in Chinese women. J Bone Miner Metab, 2003, 21(3): 184~192. (IF=1.894)

35. Wu XP, Liao EY, Huang G, Dai RC, Zhang H. A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women. Calcif Tissue Int, 2003 Aug, 73(2):122~132.

36. Luo XH, Liao EY. 1alpha, 25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metalloproteinase-1 innormal human osteoblast-like cells. Endocr Res, 2003 Aug, 29(3): 353~362.

37. Luo XH, Liao EY. Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells. Endocr Res, 2003 Aug, 29(3): 343~351.

38. Luo XH, Liao EY, Liao HJ, Jin Y, Zhou HD, Huang G. Recombinant matrix metalloproteinase-14 catalytic domain induces apoptosis in human osteoblastic SaOS-2 cells. J Endocrinol Invest, 2003, 26: 620~626. (IF=1.347)

39. Wu XP, Liao EY, Luo XH, Dai RC, Zhang H, Peng J. Age-related variation in quantitative ultrasound at the tibia and prevalence of osteoporosis in native Chinese women. Br J Radiol, 2003 Sep, 76(909): 605~610.

40. Liang M, Liao EY, Luo XH, Su X. Effects of levonorgestre on osteoblasts proliferation and differentiation. Endocrine Res, 2003, 29(4): 510~552.

41. Wu XP, Liao EY, Dai RC, Luo XH, Zhang H. Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women inChina. Br J Radiol, 2003 Jul, 76(907): 452~458.

42. Li Xia, Yang lin, Zhou Zhiguang, Huang Gan, Yan Xiang. Glutamic aeid decarboxylase 65 autoantibody levels discriminate twosubtypes of latent autoimmune dlabetes in adults. Chin med J, 2003, 116(11): 1728~1732.(IF=1.016)

43. E.Y. Liao, Y.Q. Peng, H.D. Zhou, E.J.Mackie, J.Li, P.A. Hu, S.H.Zhou, G.B.Wen, M.X. Zhai, X.H. Luo, L.H. Tan, J.D. Ni. Gene Symbol: WISP3. Disease: Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy. Hum Genet, 2004, 115: 169.

44. E.Y. Liao, Y.Q. Peng, H.D. Zhou, E.J. Mackie, J.Li, P.A. Hu, S.H.Zhou, G.B.Wen, M.X. Zhai, X.H. Luo, L.H. Tan, J.D. Ni. Gene Symbol: WISP3. Disease: Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy. Hum Genet, 2004, 115: 174.

45. E.Y. Liao, H.J. Liao, Q.Y. Wei, X.H. Luo, X.Su, Y.Q. Peng, R.C.Dai. Gene Symbol: NF2. Disease: Neurofibromatosis type 2. Hum Genet, 2004, 115: 351.

46. E.Y. Liao, X.P. Wu, H.J. Liao, H. Zhang, J. Peng. Effects of skeletal size of the lumbar spine on areal bone density, volumetric bone density, and the diagnosis of osteoporosis in postmenopausal women inChina. J Bone Miner Metab, 2004, 22: 270~277.(IF=1.894)

47. E.Y. Liao, H.J. Liao, L.J. Guo, H.D. Zhou, X.P. Wu, R.C. Dai, X.H. Luo. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo. J. Endocrinol. Invest, 2004, 27: 1~5.

48. X.P. Wu, E.Y. Liao, H. Zhang, P.F. Shan, X.Z. Cao, S.P. Liu. Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int, 2004, 15: 71~79. (IF=4.997)

49. X.H. Luo, E.Y. Liao, X. Su, X.P. Wu. Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in osteoblast-like MG-63 cells. J Bone Miner Metab, 2004, 22: 19~25. (IF=1.894)

50. X.P. Wu, E.Y. Liao, S.P. Liu, H. Zhang, P.F. Shan, X.Z. Cao, Y. Jiang. Relationship of body surface area with bone density and its risk of osteoporosis at various skeletal regions in women of mainlandChina. Osteoporos Int, 2004, 15: 751~759.(IF=4.997)

51. R.C. Dai, E.Y. Liao, C. Yang, X.P. Wu, Y. Jiang. Microcracks: an alternative index for evaluating bone biomechanical quality. J Bone Miner Metab, 2004, 22: 215~223. (IF=1.894)

52. X.P. Wu, E.Y. Liao, H. Zhang, R.C. Dai, P.F. Shan, X.Z. Cao, S.P. Liu, Y. Jiang. Determination of age-specific bone mineral density and comparison of diagnosis and prevalenc of primary osteoporosis in Chinese women based on both Chinese criteria and World Health Organization criteria. J Bone Miner Metab, 2004, 22: 382~391.(IF=1.894)

53. L.J. Guo, H. Xie, H.D. Zhou, X.H. Luo, Y.Q. Peng, E.Y. Liao. Stimulation of RANKL and inhibition of membrane-type matrix metalloproteinase-1 expression by parathyroid hormone in normal human osteoblasts. Endocrine Res, 2004, 30(3): 369~377.

54. Jian Li, E.Y. Liao, R.C. Dai, Q.Y. Wei, X.H. Luo. Effects of 17b-Estradiol on the Expression of Interstitial Collagenases-8 and -13 (MMP-8 and MMP-13) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in ovariectomized Rat Osteoblastic Cells. J Mol Histol, 2004, 35(8~9): 723~731.

55. X. Li, Z.G. Zhou, G. Huang, X. Yan, L. Yang, X.Y. Chen, J.P.Wang. Optimal Cut-off Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult-onset Latent Autoimmune Diabetes (LADA). Ann N Y Sci, 2004, 1037: 122~126.

56. Yebin Jiang, Jenny Zhao, Piet Geusens, Er-Yuan Liao, Peter Adriaensens, Jan Gelan, Mo?se Azria, Steven Boonen, Francine Caulin, John A Lynch, Xiaolong Ouyang, Harry K Genant. Femoral neck trabecular microstructure in ovariectomized ewes treated with calcitonin: MRI microscopic evaluation. J Bone Miner Res,2005, 20(1):125~130(IF=6.043)(科研类)

57. Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH,Cao XZ, Xie H, Shan PF, Liao EY. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta,2005,351:161~168. (IF=2.535)(临床类)

58. Wu XP, Yang YH, Zhang H, Yuan LQ, Luo XH,Cao XZ, Liao EY. Gender differences in bone density at different skeletal sites of acquisition with age in Chinese children and adolescents. J Bone Miner Metab,2005, 23:253~260.(IF=1.894)(临床类)

59. Xiao XH, Liao EY, Zhou HD, Dai RC, Yuan LQ, Wu XP. Ascorbic acid inhibits the differentiation of RAW264.7 cells into mature osteoclasts and reduces the formation of bone resorption pits induced by receptor activated nuclear factor kappaB ligand (RANKL) in vitro. J Endocrinol Invest,2005, 28:253~260.(IF=1.347)(科研类)

60. Wu XP, Liao EY, Dai RC, Shan PF, Fang TY, Luo XH, Pi YZ, Jiang Y. Comparison of spine and femur reference data in native Chinese women from different regions ofChina. Osteoporos Int,2005,16(10):1215~1224.(IF=4.997)(临床类)

61. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res,2005, 309:99~109.(科研类)

62. Wu XP, Dai RC, Shan PF, Yuan LQ,Cao YZ, Liao EY, Jiang Y. Establishment of BMD reference curves at different skeletal sites in women, using a Cartesian coordinate numeration system. Osteoporos Int,2005, 16(12):1655~1662.(IF=4.997)(临床类)

63. Zhou Z, Li X, Huang G, et al.Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev,2005, 21(2):203~208.(IF=2.762)(至2013-5-15引用26次)(临床类)

64. Li X, Zhou Z, Huang G, Su H, Yan X, Yang L. Metabolic Syndrome in adult-onset latent autoimmune diabetes (LADA). Metabolic Syndrome and Related Disorders, 2005, 3(2):174~180.(至2013-5-15引用0次)(临床类)

65. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res, 2006 Oct, 21(10): 1648~1656.(IF=6.043)(科研类)

66. Luo XH, Guo LJ, Shan PF, Xie H, Wu XP, Zhang H,Cao XZ, Yuan LQ, Liao EY. Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women. Osteoporos Int, 2006, 17(4): 521~526.(IF=4.997)(临床类)

67. Pi YZ, Wu XP, Liu SP, Luo XH,Cao XZ, Xie H, Liao EY. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J Bone Miner Metab, 2006, 24(5): 380~385.(IF=1.894)(临床类)

68. Yuan LQ, Xie H, Luo XH, Wu XP, Zhou HD, Lu Y, Liao EY. Taurine transporter is expressed in osteoblasts. Amino Acids, 2006 Aug, 31(2): 157~163. Epub 2006 May 26.(IF=3.877)(科研类)

69. Guo LJ, Luo XH, Xie H, Zhou HD, Yuan LQ, Wang M, Liao EY. Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. Calcif Tissue Int, 2006 May, 78(5): 285~292. (IF=IF=2.322)(科研类)

70. Guo LJ, Luo XH, Wu XP, Shan PF, Zhang H,Cao XZ, Xie H, Liao EY. Serum concentrations of MMP-1, MMP-2, and TIMP-1 inChinese women: age-related changes, and the relationships with bone biochemical markers, bone mineral density. Clin Chim Acta, 2006 Sep, 371(1~2): 137~142. (IF=2.535)(临床类)

71. Xie H, Tang SY, Cui RR, Huang J, Ren XH, Yuan LQ, Lu Y, Yang M, Zhou HD, Wu XP, Luo XH, Liao EY. Apelin and its receptor are expressed in human osteoblasts. Regul Pept, 2006 May 15, 134(2~3): 118~125.(IF=2.16)(科研类)

72. Shan PF, Wu XP, Zhang H, Luo XH,Cao XZ, Xie H, Liu SP, Pi YZ, Fang TY, Liu H, Chen ZH, Zhong N, Liao EY. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women. Clin Chim Acta, 2006 Apr, 366(1~2): 233~238.(IF=2.535)(临床类)

73. Zhang D, Zhou Z, Li L, et al. Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes. Diabet Med, 2006, 23(1): 67~71.(IF=2.871)(至2013-5-15引用2次)(临床类)

74. Xie Z *, Chang S, Yuko O and Bikle DD. Hairless suppresses vitamin D transactivation in human keratinocytes. Endocrinology, 2006, 147(1): 314-323. (IF=5.236)(科研类)

75. Sheng ZF, Dai RC, Wu XP, Fang LN, Fan HJ, Liao EY. Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats. Acta Radiol, 2007 Jun,48(5):531~539. (IF=1.27)(临床类)

76. Cui RR, Huang J, Yi L, Xie H, Zhou HD, Yuan LQ, Wang M, Peng YQ, Luo XH, Liao EY. WISP3 suppresses insulin-like growth factor signaling in human chondrocytes. Mol Cell Endocrinol, 2007 Dec 15,279(1~2):1~8. (IF=3.503)(科研类)

77. Hou YL, Wu XP, Luo XH, Zhang H,Cao XZ, Jiang YB, Liao EY.Differences in age-related bone mass of proximal femur between Chinese women and different ethnic women in theUnited States. J Bone Miner Metab, 2007,25(4):243~252. Epub 2007 Jun 25. (IF=1.894)(临床类)

78. Zhou HD, Bu YH, Peng YQ, Xie H, Wang M, Yuan LQ, Jiang Y, Li D, Wei QY, He YL, Xiao T, Ni JD, Liao EY.Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. J Mol Med, 2007 Sep,85(9):985~996. (IF=5.004)(临床类)

79. Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Guo LJ, Zhou HD, Wu XP, Liao EY. Apelin suppresses apoptosis of human osteoblasts. Apoptosis, 2007, 12(1): 247~254. (IF=4.066)(科研类)

80. Xie H, Luo XH, Huang J, Cui RR, Yuan LQ, Zhou HD, Wu XP, Liao EY. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int, 2007 Mar,80(3):201~210.(IF=2.322)(科研类)

81. Yang Y, Liao EY. Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA). Med Hypotheses, 2007, 68(6): 1406~1410.(IF=1.393)(临床类)

82. Tang SY, Shan PF, Xie H, Wu XP, Liao EY, Zhang H.Bone mineral content and bone mineral density at lumbar spine and forearm in Chinese girls aged 6-18 years. J Endocrinol Invest, 2007 Mar,30(3):205~209.(IF=1.347)(临床类)

83. Tang SY, Xie H, Yuan LQ, LuoXH, Huang J, Cui RR, Zhou HD, Wu XP, Liao EY.Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides, 2007,28(3):708~718. (IF=2.036)(科研类)

84. Yuan LQ, Lu Y, Luo XH, Xie H, Wu XP, Liao EY.Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathway. Amino Acids, 2007, 32(3): 425~430.(IF=3.877)(科研类)

85. Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA. Islet autoantibodiesare associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens, 2007, 70(5): 369~375. (IF=2.33)(至2013-5-15引用10次)(临床类)

86. Yang Z, Zhou Z, Huang G,Ling H, Yan X, Peng J, Li X. The CD4(+) regulatory T-cells is decreased in adults with latent autoimmune diabetes. Diabetes Res Clin Pract, 2007, 76(1): 126~131.(IF=2.16)(临床类)

87. Xie Z * and Bikle DD.The recruitment of phosphatidylinositol 3-kinase to the E-cadherin/catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. Journal of Biological Chemistry, 2007,282(12): 8695-8703. (IF 7.385)(科研类)

88. Wu XP, Hou YL, Zhang H, Shan PF, Zhao Q,Cao XZ, Dai RC, Luo XH, Liao EY. Establishment of BMD reference databases for the diagnosis and evaluation of osteoporosis in central southern Chinese men. J Bone Miner Metab, 2008, 26(6): 586~594. (IF=1.894)(临床类)

89. Hou YL, Liao EY, Wu XP, Peng YQ, Zhang H, Dai RC, Luo XH,Cao XZ. Effectsof the sample size of reference population on determining BMD reference curve and peak BMD and diagnosing osteoporosis. Osteoporos Int, 2008, 19(1): 71~78.(IF=4.997)(临床类)

90. Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, Liao EY.L-carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids, 2008, 35(2): 419~423. (IF=3.877)(科研类)

91. Sheng ZF, Dai RC, Wu XP, Ma YL, Xu K, Zhang YH, Jiang YB, Liao EY. The influence of center of rotation on the assessment of trabecular bone densitometric and structural properties. Ann Biomed Eng, 2008, 36(12):1934~1941.(IF=2.409)(科研类)

92. Ma YL, Dai RC, Sheng ZF, Jin Y, Zhang YH, Fang LN, Fan HJ, Liao EY. Quantitative associations between osteocyte density and biomechanics, microcrack and microstructure in OVX rats vertebral trabeculae. J Biomech, 2008, 41(6): 1324~1332. (IF=2.657)(科研类)

93. Yuan LQ, Liu YS, Luo XH, Guo LJ, Xie H, Lu Y, Wu XP, Liao EY. Recombinant tissue metalloproteinase inhibitor-3 protein induces apoptosis of murine osteoblast MC3T3-E1. Amino Acids, 2008, 35(1): 123~127. (IF=3.877)(科研类)

94. Dai R, Ma Y, Sheng Z, Jin Y, Zhang Y, Fang L, Fan H, Liao E. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J Bone Miner Metab, 2008, 26(4): 342~349. (IF=1.894)(科研类)

95. Wu XY, Wu XP, Xie H, Zhang H, Luo XH, Liu SP, Peng YQ, Dai RC, Liao EY. Relationship between age-related reference values of serum osteoprotegerin and leptin in native Chinese women and compared with those in women of other races. Clin Chim Acta, 2008, 389(1~2): 72~78.(IF=2.535)(临床类)

96. Jianghua Liu, Kang Xu, Gebo Wen, Hui Guo, San Li, Xianping Wu, Ruchun Dai, Zhifeng Sheng, Eryuan Liao. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Bone, 2008, 42(5): 950~959.(IF=4.089)(科研类)

97. Yang M,Huang L,Liu W,Sheng Z,Xie H,Liao E. Prolactin may be a promising therapeutic target for myasthenia gravis: hypothesis and importance.Med Hypotheses,2008, 70(5): 1017~1020.(IF=1.393)(科研类)

98. Lin J, Zhou ZG, Wang JP, et al.From type 1, through LADA, to type 2 diabetes: a continuous spectrum? The evidence of the HLA-DQ gene. Ann. N.Y. Acad. Sc, 2008, 1150: 99~102.(IF=2.67)(临床类)

99. Yang L, Zhou Z, Tan SZ, et al. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults. Ann. N.Y. Acad. Sc, 2008, 1150: 263~266.(IF=2.67)(至2013-5-15引用3次)(临床类)

100. Zhou HD, Bu YH, Xie H, et al.Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. BONE, 2008, 43: S48 (meeting).(IF=4.089)(临床类)

101. Zhou HD, Bu YH, Huang QX, et al.Insulin receptor substrate 2 plays important roles in 17 beta-estradiol induced bone formation. BONE, 2008, 43: S97 (meeting).(IF=4.089)(科研类)

102. Xie H, Liao EY. IC162, a New Flavonoid, Preserves Bone Mass and Microarchitecture without Affecting Uterine Weight in Ovariectomized (OVX) Rats. J Bone Miner Res, 2008, 23: S205 (meeting).(IF=6.043)(科研类)

103. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH.A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest, 2009 Dec, 119(12): 3666~3677. (IF=15.387)(临床类)

104. Zhang N, Wu XY, Wu XP, Fu XH, Du XY, Xie H, Peng YQ, Luo XH, Liao EY.Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. Clin Chim Acta. 2009 May, 403(1-2): 63~69. (IF=2.535)(临床类)

105. Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res. 2009 Aug, 24(8): 1461~1468.(IF=6.043)(科研类)

106. Liu SP, Liao EY, Chen J, Yang SM, Li JW, Sheng ZF, Mo H, Wu XP, Yao L, Dai RC.Effects of methylprednisolone on bone mineral density and microarchitecture of trabecular bones in rats with administration time and assessed by micro-computed tomography. Acta Radiol. 2009 Jan, 50(1): 93~100.(IF=1.27)(科研类)

107. Xu ZR, Wang AH, Wu XP, Zhang H, Sheng ZF, Wu XY, Xie H, Luo XH, Liao EY.Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta. 2009 Feb, 400(1-2): 8~13. (IF=2.535)(临床类)

108. Sheng ZF, Xu K, Ma YL, Liu JH, Dai RC, Zhang YH, Jiang YB, Liao EY. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. Osteoporos Int. 2009 Jan, 20(1): 151~159.(4.997)(科研类)

109. Bu YH, Peng D, Zhou HD, Huang QX, Liu W, Luo XB, Tang LL, Tang AG. Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation. J Endocrinol Invest. 2009, 32(8): 682~689.(IF=1.347)(科研类)

110. Wang QP, Xie H, Yuan LQ, Luo XH, Li H, Wang D, Meng P, Liao EY. Effect of progesterone on apoptosis of murine MC3T3-E1 osteoblastic cells.Amino Acids. 2009 Jan, 36(1): 57~63. (IF=3.877)(科研类)

111. Shan PF, Wu XP, Zhang H,Cao XZ, Gu W, Deng XG, Gu C, Liao EY. Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China. J Bone Miner Metab. 2009, 27(2): 190~197. (IF=1.894)(临床类)

112. Du T, Zhou ZG, You S, et al.Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta, 2009, 402(1-2): 133~138.(IF=2.535)(至2013-5-15引用4次)(临床类)

113. Du T, Zhou ZG, You S, et al.Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM. Diabetes Res Clin Pract, 2009, 83(2): 208~214.(IF=2.16)(至2013-5-15引用10次)(临床类)

114. Yang Z, Zhou Z, Li X, et al. Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study. Diabetes Res Clin Pract, 2009, 83(1): 54~60.(IF=2.16)(至2013-5-15引用8次)(临床类)

115. Li X, Liao L, Yan X, et al.Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev, 2009, 25(5): 411~416.(IF=2.762)(至2013-5-15引用27次)(临床类)

116. Xie Z*, Chang SM, Pennypacker SD, Liao E-Y and Bikl DD. Phosphatidylinositol 4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation. Molecular Biology of the Cell, 2009,20(6): 1695-1704. (IF=9.376)(科研类)

117. Yang L(杨琳), Luo S, Huang G, Peng J, Li X, Yan X, Lin J, Wenzlau JM, Davidson HW, Hutton JC, Zhou Z*. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev, 2010, 26 (7):579-584 (IF=2.762)(至2013-5-15引用10次)(临床类)

118. Hu R(胡蓉),Li H,Liu W,Yang L,Tan YF,Luo XH*. Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets,2010, 14(10):1109-20. (IF=3.713)(至2013-5-15引用12次)(科研类)

119. Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH*. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta. 2010 May 2,411(9-10):771-5.(IF=2.535)(至2013-5-15引用14次)(临床类)

120. Xie H, Tang LL, Luo XH, Wu XY, Wu XP, Zhou HD, Yuan LQ, Liao EY*. Suppressive effect of dexamethasone on TIMP-1 production involves murine osteoblastic MC3T3-E1 cell apoptosis. Amino Acids. 2010 Apr,38(4):1145-53. (IF=3.877)(科研类)

121. Wu XY(伍西羽), Wu XP*, Luo XH, Xie H, Zhang H, Peng YQ, Yuan LQ, Jiang YB, Liao EY*. The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. Clin Chim Acta. 2010 Sep 6,411(17-18):1296-305. (IF=2.535)(临床类)

122. Zhang H(张红), Xie H, Zhao Q, Xie GQ, Wu XP, Liao EY, Luo XH*. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. J Endocrinol Invest. 2010 Nov,33(10):707-11. (IF=1.347)(临床类)

123. Yuan LQ, Liu W, Cui RR, Wang D, Meng JC, Xie H, Wu XP, Zhou HD, Lu Y, Liao EY*.Taurine inhibits osteoclastogenesis through the taurine transporter. Amino Acids. 2010 Jun,39(1):89-99. (IF=3.877)(科研类)

124. Wu XY, Wu XP*, Xie H, Zhang H, Peng YQ, Yuan LQ, Su X, Luo XH, Liao EY*. Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women. Osteoporos Int. 2010 Feb,21(2):275-85. (IF=4.997)(临床类)

125. Sheng ZF, Ye W, Wang J, Li CH, Liu JH, Liang QC, Li S, Xu K, Liao EY.OPG knockout mouse teeth display reduced alveolar bone mass and hypermineralization in enamel and dentin. Arch Oral Biol. 2010 Apr,55(4):288-93.(IF=1.649)(科研类)

126. Bu YH, He YL, Zhou HD*, Liu W, Peng D, Tang AG, Tang LL,Xie H, Huang QX, Luo XH, Liao EY.Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. J Endocrinol. 2010 Sep,206(3):271-7. (IF=2.86)(科研类)

127. Xie Z*, Chen Y, Liao EY, Jiang Y, Liu FY, Pennypacker SD.Phospholipase C-g1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis.Biochemical and Biophysical Research Communications, 2010, 397(2): 296-300(IF= 2.595)(科研类)

128. Xie Z* , Chen Y, Pennypacker SD, Zhou Z, Peng D.The SH3 domain, but not the catalytic domain, is required for phospholipase C-g1 to mediate epidermal growth factor-induced mitogenesis.Biochemical and Biophysical Research Communications, 2010, 398(4):719-722 (IF= 2.595)(至2013-5-15引用1次)(科研类)

129. Xie Z*, Peng J,PennypackerSD, Chen Y. Critical role for the catalytic activity of phospholipase C-1 inepidermal growth factor-induced cell migration. Biochemical and Biophysical Research Communications, 2010, 399(3):425-8(IF=2.595)(科研类)

130. Xie H, Yang B, Zhou XM, Song FL, Li JM, Zhou K, Hu W, Peng YQ, Tang SY, Yuan LQ, Xiong SY, Liao XB*. L-carnitine and taurine synergistically inhibit the proliferation and osteoblastic differentiation of vascular smooth muscle cells. Acta Pharmacol Sin. 2010 Mar,31(3):289-96. (IF=1.783)(至2013-5-15引用2次)(科研类)

131. Cui RR,Mao DA,Yi L,Wang C,Zhang XX,Xie H,Wu XP,Liao XB,Zhou H,Meng JC,Yuan LQ*,Liao EY*.Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways. Amino Acids. 2010, 39(5):1193-200. (IF=3.877)(科研类)

132. Liao XB,Peng YQ,Zhou XM,Yang B,Zheng Z,Liu LM,Song FL,Li JM,Zhou K,Meng JC,Yuan LQ,Xie H*. Taurine restores Axl/Gas6 expression in vascular smooth muscle cell calcification model. Amino Acids,2010, 39(2): 375-83(IF=3.877)(至2013-5-15引用5次)(科研类)

133. Xiang Y,Zhou P,Li X,Huang G,Liu Z,Xu A,Leslie RD,Zhou Z*. Heterogeneity of Altered Cytokine Levels Across the Clinical Spectrum of Diabetes inChina. Diabetes Care, 2011, 34(7): 1639-1641 (IF=7.141)(至2013-5-15引用5次)(临床类)

134. Wang A, Liu M, Liu X, Dong LQ, Glickman RD, Slaga TJ, Zhou Z*, Liu F. Up-regulation of adiponectin by resveratrol: The essential roles of the Akt/FOXO1 and AMPK signaling pathways and DsbA-L. J Biol Chem, 2011, 286 (1):60-66 (IF=5.328)(Liu ML与刘峰共同通讯作者,我院第二通讯作者,属合作论文)(科研类)

135. Li YJ, Zhao M, Hou C, Liang GP, Yang L,Tan YY, Wang Z, Yin H, Zhou ZG,* Lu QJ. Abnormal DNA methylation in CD4(+) T cells from people with latent autoimmune diabetes in adults. Diabetes Research and Clinical Pratice, 2011, 94(2): 242-248 (IF=2.134)(临床类)

136. Jin P, Huang G, Lin JA, Yang L, Xiang B, Zhou WD, Zhou ZG*. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clinical Endocrinology, 2011, 74(5): 587-592 (IF=3.201)(至2013-5-15引用7次)(临床类)

137. Zheng C, Zhou ZG*, Yang L, Lin JA, Huang G, Li X, Zhou WD, Wang XB, Liu ZQ. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes-Metabolism Research and Reviews, 2011, 27(1): 70-78 (IF=2.426)(至2013-5-15引用9次)(临床类)

138. Jin P, Huang G, Lin J, Luo SM, Zhou ZG*. Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity. Acta Diabetologica, 2011, 48(2): 149-155 (IF=1.549)(临床类)

139. Wang Z, Zheng C, Tan Y, Li YJ, Yang L, Huang G, Lin J, Zhou ZG*. Gene expression changes in patients with fulminant type 1 diabetes. Chin Med J (Engl), 2011, 124 (22):3613-3617.(IF=1.016)(至2013-5-15引用0次)(临床类)

140. Li H, Xiao Y, Liu H, Chen XY, Li XY, Tang WL, Liu SP, Xu A, Zhou ZG*. Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients:an 8-year prospective study. Chin Med J (Engl), 2011, 124 (22):3607-3612.(IF=1.016)(至2013-5-15引用0次)(临床类)

141. Liu S, Li J, Sheng Z, Wu X, Liao E*. Relationship between body composition and age, menopause and its effects on bone mineral density at segmental regions in Central Southern Chinese postmenopausal elderly women with and without osteoporosis. Arch Gerontol Geriatr.(IF=1.525)2011,53(2):192-7.(至2013-5-15引用0次)(临床类)

142. Xie H, Sun M, Liao XB, Yuan LQ, Sheng ZF, Meng JC, Wang D, Yu ZY, Zhang LY, Zhou HD, Luo XH, Li H, Wu XP, Wei QY, Tang SY, Wang ZY, Liao EY*. Estrogen Receptor alpha 36 Mediates a Bone-Sparing Effect of 17 beta-Estrodiol in Postmenopausal Women. Journal of Bone and Mineral Research, 2011, 26(1):156-168 (IF=7.056)(科研类)

143. Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP, Luo XH*. A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation. Journal of Biological Chemistry, 2011,286(14): 12328-12339 (IF=5.328)(至2013-5-15引用24次)(科研类)

144. Xiao LW, Yang M, Dong J, Xie H, Sui GL, He YL, Lei JX, Liao EY*, Yuan X. Stretch-inducible Expression of Connective Tissue Growth Factor (CTGF) in Human Osteoblasts-like Cells is Mediated by PI3K-JNK Pathway. Cellular Physiology and Biochemistry, 2011, 28(2): 297-304 (IF=3.563)(科研类)

145. Zhou XW, Wu XY, Luo L, Guo LJ, Lei MX, Zhang H, Xie H, Peng YQ, Wu XP*, Liao EY*. The relationship between bone turnover markers and BMD decreasing rates in Chinese middle-aged women. Clinica Chimica Acta, 2011, 412(17-18): 1648-1657 (IF=2.535)(临床类)

146. Zhang H*, Bu P, Xie YH, Luo JA, Lei MX, Mo ZH, Liao EY. Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in newly diagnosed type 2 diabetics. Chinese Medical Journal, 2011, 124(2): 172-176 (IF=0.952)(临床类)

147. Xie H, Xie PL, Wu XP, Chen SM, Zhou HD, Yuan LQ, Sheng ZF, Tang SY, Luo XH, Liao EY*. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovascular Research, 2011, 92(2): 296-306 (IF=6.015)(科研类)

148. Yuan LQ,Zhu JH,Wang HW,Liang QH,Xie H,Wu XP,Zhou H,Cui RR,Sheng ZF,Zhou HD,Zhu X,Liu GY,Liu YS*,Liao EY*. RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells. Plos One, 2011, 6(12): e29037 (IF=4.616)(科研类)

149. Sheng Z, Xu K, Ou Y, Dai R, Luo X, Liu S, Su X, Wu X, Xie H, Yuan L, Liao E*. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2011 Mar,74(3):319-24. (IF=3.321)(临床类)

150. Hu F, Liu F*. Mitochondrial stress: A bridge between mitochondrial dysfunction and metabolic diseases. Cellular Signalling, 2011, 23(10): 1528-1533 (IF=4.243)(刘峰,国外通讯地址,我院第四作者单位,属合作论文)(至2013-5-15引用5次)(科研类)

151. Xiao Y, Xu A, Law LS, Chen C, Li H, Li X, Yang L, Liu S, Zhou Z, Lam KS. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes. J Clin Endocrinol Metab. 2012 Jan;97(1):E54-8.(与香港大学合作论文,第一作者单位为中南大学湘雅二医院,通讯作者单位为中南大学湘雅二医院和香港大学)(IF=5.967)(至2013-5-15引用3次)(临床类)

152. Huang G, Wang X, Li Z, Li H, Li X, Zhou Z. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol. 2012 Oct;49(5):327-31.(IF=2.784)(至2013-5-15引用1次)(临床类)

153. Huang G, Mo X, Li M, Xiang Y, Li X, Luo S, Zhou Z. Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetes. Acta Diabetol. 2012 Oct;49(5):395-9.(IF=2.784)(至2013-5-15引用0次)(临床类)

154. Xiang Y, Peng J, Tai N, Hu C, Zhou Z, Wong FS, Wen L. The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol. 2012 May 15;188(10):4747-58.(与耶鲁大学合作论文,第一作者单位为耶鲁大学,中南大学湘雅二医院代谢内分泌研究所、糖尿病免疫学教育部重点实验室,中南大学糖尿病中心。通讯作者单位为耶鲁大学。)(IF=5.65)(至2013-5-15引用1次)(科研类)

155. Xiang Y, Huang G, Zhou W, Che Z, Zhou P, Zhou Z. Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study. BMC Public Health. 2012 Aug 20; 12(1): 675.(已出电子版)(IF=1.997)(至2013-5-15引用0次)(临床类)

156. Xie Z*, Jiang Y, Liao EY, Chen Y, Pennypacker SD, Peng J, Chang SM. PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells. Oncogene, 2012 Dec 6;31(49): 5090-8 (IF=6.373)(科研类)

157. Peng J, Liao L, Chen Y, Pennypacker SD, Gao X, Zhou SH,Xie Z(通讯作者). Two distinct mechanisms by which phospholipase C-γ1 mediates epidermal growth factor-induced keratinocyte migration and proliferation. J Dermatol Sci. 2012, 67(3):199-202. (IF= 3.718).(科研类)

158. He J, Tang Q, Dai R, Li Z, Jiang Y.Problem-, team- and evidence-based learning. Med Educ. 2012 Nov;46(11):1102-3.(通讯作者:戴如春)(IF=2.639)(至2013-5-15引用0次)(科研类)

159. Yang L, Cheng P, Chen C, He HB, Xie GQ, Zhou HD, Xie H, Wu XP, Luo XH.miR-93/Sp7 function loop mediates osteoblast mineralization.J Bone Miner Res. 2012 Jul;27(7):1598-606. doi: 10.1002/jbmr.1621.(研究生:杨丽)(IF=6.373)(至2013-5-15引用3次)(科研类)

160. Xie H, Xie PL, Luo XH, Wu XP, Zhou HD, Tang SY, Liao EY*.Omentin-1 exerts bone-sparing effect in ovariectomized mice.Osteoporos Int. 2012 Apr;23(4):1425-36. Epub 2011 Jul 14.(IF=4.58)(科研类)

161. Liang QH, Jiang Y, Zhu X, Cui RR, Liu GY, Liu Y, Wu SS, Liao XB, Xie H, Zhou HD, Wu XP, Yuan LQ, Liao EY. Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway.PLoS One. 2012;7(4):e33126. Epub 2012 Apr 13.(研究生:梁秋华)(IF=4.2)(科研类)

162. Cui RR, Li SJ, Liu LJ, Yi L, Liang QH, Zhu X, Liu GY, Liu Y, Wu SS, Liao XB, Yuan LQ*, Mao DA*, Liao EY*.MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo.Cardiovasc Res. 2012 Nov 1; 96(2):320-9.(第一通讯作者单位湘雅二医院内分泌)(IF=6.064)(科研类)

163. Zhang Z, Shen X, Zhang H, Li S, Zhou H, Wu X, Sheng Z, Liao E. The relationship between body composition and fracture risk using the FRAX model in central south Chinese postmenopausal women. Clinical Endocrinology, 2012,77(4): 524-530(研究生:张志敏)(IF=3.323)(临床类)

164. Lu Y, Zhu X, Liang GX, Cui RR, Liu Y, Wu SS, Liang QH, Liu GY, Jiang Y, Liao XB, Xie H, Zhou HD, Wu XP, Yuan LQ, Liao EY. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells.Amino Acids. 2012 Nov;43(5):2125-36.(研究生:卢瑛,通讯作者单位)(IF=4.106)(科研类)

165. Wang QP, Yang L, Li XP, Xie H, Liao EY, Wang M, Luo XH.Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. Bone. 2012 Sep;51(3):515-23. Epub 2012 May 23.(研究生:王清平,通讯作者单位)(IF=4.843)(科研类)

166. Sheng ZF, Ma YL, Tong D, Fang DY, Liang QC, Liu LH, Zhang J, Liao EY.Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis.Ann Biomed Eng. 2012 Mar;40(3): 657-65.(IF=2.374)(科研类)

167. Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, Zhou J, Zhang J, Liao E. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf), 2012 Jun; 76(6): 797-801.(IF=3.323)(临床类)

168. Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, Yang L, Lin J, Liu Z, Hagopian WA, Leslie RD; LADA China Study Group. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.Diabetes. 2013 Feb;62(2):543-50.( IF=8.286)(至2013-5-15引用2次)(临床类)

169. Wang Z, Zheng Y, Hou C, Yang L, Li X, Lin J, Huang G, Lu Q, Wang CY,Zhou Z. DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes.J Autoimmun. 2013 Mar;41:50-9.(IF=8.145)

170. Li Z,Zhou Z, Huang G, Hu F, Xiang Y, He L.Exendin-4 protects mitochondria from reactive oxygen species induced apoptosis in pancreatic Beta cells.PLoS One. 2013 Oct 24;8(10):e76172.(IF=3.534)

171. Xiao Y, Xu A, Hui X, Zhou P, Li X, Zhong H, Tang W, Huang G,Zhou Z. Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes. PLoS One. 2013 Jun 17;8(6):e66607.(IF=3.73)

172. Li X, Huang G, Lin J, Yang L,Zhou Z. Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptide.BMC Endocr Disord. 2013 Mar 1;13:10 (IF=1.673)

173. Xiang Y,ZhouZ, Deng C, Leslie RD. Latent autoimmune diabetes in adults in Asians: similarities and differences between East and West. J Diabetes. 2013 Jun;5(2):118-26.(IF=2.939)

174. Huang G, Xiang Y, Pan L, Li X, Luo S,Zhou Z. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.Diabetes Metab Res Rev. 2013 Jul;29(5):363-8.(IF=2.968)

175. Wang AP, Li X, Zheng Y, Liu BL, Huang G, Yan X, Liu Z,Zhou Z. Thiazolidinediones protect mouse pancreatic beta-cells directly from cytokine-induced cytotoxicity through PPAR gamma-dependent mechanisms.Acta Diabetol.2013 Apr;50(2):163-73.(IF=4.631)

176. Luo S, Zhang Z, Li X, Yang L, Lin J, Yan X, Wang Z, Zheng C, Huang G,Zhou Z. Fulminant type 1 diabetes: a collaborative clinical cases investigation in China.Acta Diabetol. 2013 Feb;50(1):53-9.(IF=4.631)

177. Chao C, Huang G, Li X, Yang L, Lin J, Jin P, Luo SM, Zhang YY, Pan LL,Zhou ZG. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus.Chin Med J (Engl).2013 Nov;126(21):4006-12.(IF=0.901)

178. Deng C, Xiang YF,Zhou ZG.Biologic therapies in type 1 diabetes: how far are they from us? Chin Med J (Engl). 2013 Nov;126(21):4003-5.(IF=0.901)

179. Xiang YF, Zhao YJ,Zhou ZG. Latent autoimmune diabetes in adults: evidences for diabetes spectrum? Chin Med J (Engl). 2013 Feb;126(4):783-8.(IF=0.901)

180. Cheng P(程鹏), Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY, Luo XH*. miR-148aregulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res. 2013 May; 28(5):1180-90. (IF=6.128)科研类

181. Xie GQ(谢亘青), Lei DD, He HB, Gong JJ, Chen C, Chen P, Zhang H, Luo XH*, Liao EY, Wu XP. Relationship between serum TGF-beta 1, OPG levels and osteoporotic risk in native Chinese women. Clin Chim Acta. 2013 Aug 23;423:116-21(IF=2.85)(科研类)

182. Wu XY(伍西羽), Yu SJ, Zhang H, Xie H, Luo XH, Peng YQ, Yuan LQ, Dai RC, Sheng ZF, Liu SP, Wu XP*, Liao EY .Early bone mineral density decrease is associated with FSH and LH, not estrogen. Clin Chim Acta. 2013 Jan 16;415:69-73.(IF=2.85)(临床类)

183. Wu B(吴博), Zhang C, Chen B, Zhang L, Dai R*, Wu X, Jiang Y, Liao E. Self-repair of rat cortical bone microdamage after fatigue loading in vivo. Int J Endocrinol. 2013; 2013: 321074. (IF=2.518)(科研类)

184. Wu XY(伍西羽), Peng YQ, Zhang H, Xie H, Sheng ZF, Luo XH, Dai RC, Zhou HD, Wu XP*, Liao EY. Relationship between Serum Levels of OPG and TGF-beta with Decreasing Rate of BMD in Native Chinese Women. Int J Endocrinol. 2013; 2013: 727164. (IF=2.518)(临床类)

185. Liu Y, Song CY, Wu SS, Liang QH, Yuan LQ, Liao EY*. Novel adipokines and bone metabolism. Int J Endocrinol. 2013; 2013: 895045. (IF=2.518)()

186. Wang M(王敏), Man XF, Liu YQ, Liao EY, Shen ZF, Luo XH, Guo LJ, Wu XP, Zhou HD*. Dysfunction of collagen synthesis and secretion in chondrocytes induced by wisp3 mutation. Int J Endocrinol. 2013;2013:679763. (IF=2.518)(科研类)

187. Zhang H, Chai X, Li S, Zhang Z, Yuan L, Xie H, Zhou H, Wu X, Sheng Z*, Liao E. Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine. 2013 Jun;43(3):643-50. (IF=2.25)(临床类)

188. Huang J, Huang H, Wu M, Li J, Xie H, Zhou H, Liao E, Peng Y*. Connective tissue growth factor induces osteogenic differentiation of vascular smooth muscle cells through ERK signaling. Int J Mol Med. 2013 Aug;32(2):423-9. (IF=1.957)()

189. Liao XB(廖晓波), Zhang ZY, Yuan K, Liu Y, Feng X, Cui RR, Hu YR, Yuan ZS, Gu L, Li SJ, Mao DA, Lu Q, Zhou XM, de Jesus Perez VA, Yuan LQ*. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology. 2013 Sep;154(9): 3344-52. (IF=4.717)

190. Shan PF(单鹏飞), Xian CJ, Li M, Xiang GD, Yuan LQ*. Osteoporosis. Int J Endocrinol. 2013; 2013: 952858. (IF=2.518)

191. Zhu X(), Jiang Y, Shan PF, Shen J, Liang QH, Cui RR, Liu Y, Liu GY, Wu SS, Lu Q, Xie H, Liu YS, Yuan LQ*, Liao EY*. Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway. Amino Acids. 2013 Mar;44(3):961-8. (IF=3.914)

192. Liu Y, Song CY, Wu SS, Liang QH, Yuan LQ*, Liao EY*. Novel adipokines and bone metabolism. Int J Endocrinol. 2013; 2013: 895045 (IF=2.518)

193. Wu SS, Liang QH, Liu Y, Cui RR, Yuan LQ*, Liao EY*. Omentin-1 Stimulates Human Osteoblast Proliferation through PI3K/Akt Signal Pathway. Int J Endocrinol. 2013; 2013:368970. (IF=2.518)

194. Liang QH, Liu Y, Wu SS, Cui RR, Yuan LQ*, Liao EY*. Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway. Toxicol Appl Pharmacol. 2013 Nov 1;272(3):591-7. (IF=3.975)

195. Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L, Li C, Xie L, Crane J, Wan M, Zhen G, Bian Q, Yu B, Chang W, Qiu T, Pickarski M, Duong le T, Windle JJ, Luo X, Liao E,Cao X. PDGF-BBsecreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med.2014Nov;20(11):1270-8.(IF=28.054)(非第一作者单位)

196. Xie Z, Santora AC, Shapses SA, Wang X. Vitamin d binding protein and vitamin d levels.Int J Endocrinol.2014:638263. doi: 10.1155/2014/638263. Epub 2014 Jun 25.(IF=2.518)

197. Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY, Luo XH. MiR-503 Regulates Osteoclastogenesis via Targeting RANK. Journal of bone and mineral research, 2014, 29(2): 338-347.(IF=6.589)

198. Wu XY, Zhang H, Xie H, Luo XH, Peng YQ, Yuan LQ, Dai RC, Sheng ZF, Wu XP, Liao EY. Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females inChina. Osteoporos Int.2014Mar;25(3):943-52.(IF=4.165)

199. Zhang Z,Ou Y,Sheng Z,Liao E. How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine, 2014, 45(2): 195-197(IF=3.527)

200. Li S, Ou YN, Zhang HB, Zhang ZM, Zhou HD, Liu LH, Sheng ZF, Liao EY. Vitamin D Status and Its Relationship with Body Composition, Bone Mineral Density and Fracture Risk in Urban Central South Chinese Postmenopausal Women. Ann Nutr Metab, 2014:64:13-19(IF=2.747)

201. Chen C, Liang MK, Zhang H, Peng YQ, Wu XP, Wu XY, Liao EY. Relationships between age-related biochemical markers of bone turnover and OPG, TGF-β1 and TGF-β2 in native Chinese women. Endocr Res.2014;39(3):105-14.(IF=1.409)

202. Wu XY, Li HL, Xie H, Luo XH, Peng YQ, Yuan LQ, Sheng ZF, Dai RC, Wu XP, Liao EY.Age-related bone turnover markers and osteoporotic risk in native Chinese women. BMC Endocr Disord.2014Jan 22;14:8.(IF=2.65)

203. Liu GY, Liang QH, Cui RR, Liu Y, Wu SS, Shan PF, Yuan LQ, Liao EY. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression. Endocrinology. 2014 Feb;155(2):558-67.(IF=4.644)

204. Tan T, Xiang Y, Chang C, Zhou Z. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol.2014Oct;47(2):234-43.(IF=4.728)

205. Zhao Y, Yang L, Xiang Y, Liu L, Huang G, Long Z, Li X, Leslie RD, Wang X, Zhou Z. Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study. J Clin Endocrinol Metab.2014May;99(5):E876-80.(IF=6.31)

206. Zhao Y, Yang L, Zhou Z. Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs. J Diabetes. 2014 Jan;6(1):21-9. (IF=2.349)

207. Wang Y, Xiao Y, Zhong L, Ye D, Zhang J, Tu Y, Bornstein SR4, Zhou Z, Lam KS, Xu A. Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With β-Cell Autoimmunity in Patients With Type 1 Diabetes. Diabetes,2014 Dec;63(12):4239-48.(IF=8.474)(并列第一作者)

208. Xie Z, Chang C, Zhou Z. Molecular mechanisms in autoimmune type 1 diabetes: a critical review. Clin Rev Allergy Immunol, 2014 Oct;47(2):174-92; 2014 Oct;47(2):258.(IF=4.728)

209. Zhao Y(赵云娟), Yang L, Wang X, Zhou Z. The New insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes. Diabetes Metab Res Rev, 2014 Nov;30(8):646-53.(IF=3.593)

210. Luo Y(罗岩), He F, Hu L, Hai L, Huang M, Xu Z, Zhang J, Zhou Z, Liu F, Dai YS. Transcription Factor Ets1 Regulates Expression of Thioredoxin-Interacting Protein and Inhibits Insulin Secretion in Pancreatic beta-Cells. PloS One, 2014, 4;9(6): e99049(IF=3.534)

211. Hu F, Liu F. Targeting tissue-specific metabolic signaling pathways in aging: the promise and limitations. Protein Cell. 2014 Jan;5(1):21-35.(IF=2.851)

212. Zhang H, Liang L, Xie Z. Low Vitamin D Status is Associated with Increased Titers of Thyroid Stimulating Hormone Receptor Antibodies in Graves' Disease. Endocr Pract. 2014 Nov 4:1-23.(2.588)(未被Web of science数据库收录)

213. Liu B,Liu F. Feedback regulation of mTORC1 by Grb10 inmetabolism and beyond. Cell Cycle, 2014 Sep 1;13(17):2643-4.(IF=5.006)(未被Web of science数据库收录)

214. Wu D, Li X, Tao C,Dai R*, Ni J, Liao E. Association of microstructural and mechanical properties of cancellous bone and their fracture risk assessment tool scores. Int J Clin Exp Med. 2015,15;8(3):3956-64. (IF=1.227) (Article)

215. Shidi Hu, Jin Li, Lu Liu, Ruchun Dai*, Zhifeng Sheng, Xianping Wu, Xiqiao Feng, Xuefeng Yao, Eryuan Liao, Evan Keller, Yebin Jiang. Micro/Nanostructures and Mechanical Properties of Trabecular Bone in Ovariectomized Rats. Int J Endocrinol. 2015; 2015: 252503. Published online 2015 July 27. doi: 10.1155/2015/252503(IF= 1.948) (Article)

216. Chang-Jun Li, Peng Cheng, Meng-Ke Liang, Yu-Si Chen, Qiong Lu, Jin-Yu Wang, Zhu-Ying Xia, Hou-De Zhou, Xu Cao, Hui Xie, Er-Yuan Liao, and Xiang-Hang Luo. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest, 2015,1; 125(4): 1509-1522. (IF=13.215) (Article)

217. 李爽Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women(IF=3.457) (Article)

218. Yi Jiang1*, Liyan Liao1*, Chandrama Shrestha2, Shangli Ji2, Ying Chen3, Jian Peng2, Larry Wang4, Eryuan Liao2, Zhongjian Xie2. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma. Int J Clin Exp Pathol, 2015; 8(8): 9042-9051.(IF=1.891)(Article)

219. Jiang Y, Liao L-Y, Li D-Q, L M-R, Mu Y, Xie Z. Inhibition of 4-Nitroquinoline-1-oxide-induced Oral Carcinogenesis by Dietary Calcium. Int J Clin Exp Pathol, 2015; 8(4): 3529–3542 (IF=1.891) (Article)

220. Zhang H, Lu H, Shrestha C, Feng Y, Li Y, Peng J, Li Y, Xie Z*. In serum, higher parathyroid hormone but not lower vitamin D status is associated with oral squamous cell carcinoma. Curr Oncol 2015 22(4):e259-63(IF=1.785) (Article)

221. Zhang H, Liang L, Xie Z*. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. Endocr Pract. 2015,21(3):258-63. (IF=2.811) (Article)

222. Xiao-Bo Liao, Vinicio A. de Jesus Perez, Magdalena Król, Chi-Hsiao Yeh, Ling-Qing Yuan*. MicroRNA and Cardiovascular Disease. Biomed Res Int. 2015; 2015: 734380. (IF=1.579) (Article)

223. Yuan LQ, Ouyang HW, Andersen TL, Jiang Y, Pantano F, Shan PF. Osteoporosis 2014. Int J Endocrinol. 2015;2015:567593. (IF=1.948)(Editorial Material)

224. Wu SS, Lin X, Yuan LQ, Liao EY. The Role of Epigenetics in Arterial Calcification. Biomed Res Int. 2015;2015:320849. (IF=1.579)(Review)

225. Lin X, Xiong D, Peng YQ, Sheng ZF, Wu XY, Wu XP, Wu F, Yuan LQ, Liao EY. Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives. Clin Interv Aging. 2015,25;10:1017-33. (IF=2.077) (Review)

226. Jiang Y(蒋莹玲), Huang W, Wang J, Xu Z, He J, Lin X, Zhou Z, Zhang J. Metformin Plays a Dual Role in MIN6 Pancreatic β Cell Function through AMPK-dependent Autophagy. Int J Biol Sci. 2014 Feb 20;10(3): 268-77.(IF=4.509)(Article)

227. 郑沛林Molecular mechanisms of functional natural killer deficiency in patients with partial DiGeorge syndrome(IF=11.476) (Article)

228. Zheng P, Zhou Z. Human Cancer Immunotherapy with PD-1/PD-L1 Blockade. Biomark Cancer. 2015,20;7(Suppl 2):15-8. (Article)

229. Hao-Neng Tang, Xiao-Fei Man, Ya-Qing Liu, Yue Guo, Ai-Guo Tang, Er-Yuan Liao and Hou-De Zhou. Dose-dependent effects of neuropeptide Y on the regulation of preadipocyte proliferation and adipocyte lipid synthesis via the PPARγ pathways. Endocrine Journal, 2015, 62(9): 835-846(IF=1.997) (Article)

230. Cao CQ(曹楚琴), Xiang YF, Zhou ZG*. The clinical application of linagliptin in Asians. Ther Clin Risk Manag. 2015,16;11:1409-19. (IF=1.469) (Review)

231. Jin P(金萍), Xiang B, Huang G, Zhou Z*. The association of cytotoxic T-lymphocyte antigen-4 +49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults. J Endocrinol Invest. 2015,38(2):149-54. (IF=1.448) (Article)

232. Xiang Y(向宇飞), Huang G, Shan Z, Pan L, Luo S, Yang L, Shi L, Li Q, Leslie RD, Zhou Z*. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetol. 2015,52(6):1121-7. (IF=2.399) (Article)

233. Yang Xiao(肖扬), Lingjiao Liu, Aimin Xu, Pengcheng Zhou, Zhaofeng Long, Yiting Tu, Xiaoyan Chen, Weili Tang, Gan Huang, and Zhiguang Zhou*. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2015; 14: 72. (IF= 4.015) (Article)

234. Yi, Bo. Current and Future Clinical Applications of Zinc Transporter-8 inType 1 Diabetes Mellitus (IF= 1.053) (Review)

235. Tan T, Xiang Y, Chang C, Zhou Z. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol.2014Oct;47(2):234-43.(IF=4.728)(Review)

236. Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z; LADA China Study Group. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care. 2015,38(1):16-21. (IF=8.42) (Editorial Material)

237. Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z; LADA China Study Group. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care. 2015,38(1):16-21. (IF=8.42) (Article)

238. 何斌斌Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus. (IF=1.932) (Review)

239. 郑瑛miR-101aand miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction(IF=3.676) ) (Article)

240. Yi Sun, Demao Zhu, Guihua Wang, Di Wang, Huashan Zhou, Xueting Liu, Manli Jiang, Lingjuan Liao, Zhiguang Zhou, and Jinyue Hu. Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma. PLoS One. 2015; 10(7): e0132677. (IF= 3.234) (Article)

241. Hu S, Li J, Liu L, Dai R, Sheng Z, Wu X, Feng X, Yao X, Liao E, Keller E, Jiang Y. Micro/Nanostructures and Mechanical Properties of Trabecular Bone in Ovariectomized Rats. Int J Endocrinol. 2015;2015:252503. (IF=1.948)

242. Chen M, Zhang J, Hu F,Liu S*, Zhou Z. Metformin affects the characteristics of HepG2 cells by regulating macrophage polarization in a co-culture microenvironment. Diabetes Metab Res Rev. 2015, 31(8):781-9. (IF=3.553)

243. Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes - a solid or leaky concept? Pediatr Diabetes. 2015,16(7):485-92. (IF=2.569)

244. Chen Y, Jiang Y, Liao L, Zhu X, Tang S, Yang Q, Sun L, Li Y, Gao S, Xie Z*. Inhibition of 4NQO-Induced Oral Carcinogenesis by Dietary Oyster Shell Calcium. Integr Cancer Ther. 2015. (IF=2.361)(打印稿)